文献

J-GLOBAL ID：201902263277807697   整理番号：19A0734840

マスク2017:現実世界の証拠を用いた鼻炎と喘息の多吸収性のためのARIAディジタルにより可能にされ,統合された個人中心のケア【JST・京大機械翻訳】

MASK 2017: ARIA digitally-enabled, integrated, person-centred care for rhinitis and asthma multimorbidity using real-world-evidence

著者 (113件)： Bousquet J. (MACVIA-France, Fondation Partenariale FMC VIA-LR, CHRU Arnaud de Villeneuve, Montpellier, France) ,  Bousquet J. (INSERM U 1168, VIMA: Ageing and Chronic Diseases Epidemiological and Public Health Approaches, Villejuif, Universite Versailles St-Quentin-en-Yvelines, UMR-S 1168, Montigny le Bretonneux, France) ,  Bousquet J. (Euforea, Brussels, Belgium) ,  Arnavielhe S. (KYomed-INNOV, Montpellier, France) ,  Bedbrook A. (MACVIA-France, Fondation Partenariale FMC VIA-LR, CHRU Arnaud de Villeneuve, Montpellier, France) ,  Bewick M. (iQ4U Consultants Ltd, London, UK) ,  Laune D. (KYomed-INNOV, Montpellier, France) ,  Mathieu-Dupas E. (KYomed-INNOV, Montpellier, France) ,  Murray R. (MedScript Ltd, Dundalk, Ireland) ,  Onorato G. L. (MACVIA-France, Fondation Partenariale FMC VIA-LR, CHRU Arnaud de Villeneuve, Montpellier, France) ,  Pepin J. L. (Laboratoire HP2, Grenoble, INSERM, U1042, Universite Grenoble Alpes, Grenoble, France) ,  Pepin J. L. (CHU de Grenoble, Grenoble, France) ,  Picard R. (Conseil General de l’Economie Ministere de l’Economie, de l’Industrie et du Numerique, Paris, France) ,  Portejoie F. (MACVIA-France, Fondation Partenariale FMC VIA-LR, CHRU Arnaud de Villeneuve, Montpellier, France) ,  Costa E. (UCIBIO, REQUINTE, Faculty of Pharmacy and Competence Center on Active and Healthy Ageing, University of Porto (Porto4Ageing), Porto, Portugal) ,  Fonseca J. (Center for Health Technology and Services Research- CINTESIS, Faculdade de Medicina, Universidade do Porto, Porto, Portugal) ,  Fonseca J. (Medida, Lda, Porto, Portugal) ,  Lourenco O. (Faculty of Health Sciences and CICS - UBI, Health Sciences Research Centre, University of Beira Interior, Covilha, Portugal) ,  Morais-Almeida M. (Allergy Center, CUF Descobertas Hospital, Lisbon, Portugal) ,  Todo-Bom A. (Imunoalergologia, Centro Hospitalar Universitario de Coimbra and Faculty of Medicine, University of Coimbra, Coimbra, Portugal) ,  Cruz A. A. (ProAR - Nucleo de Excelencia em Asma, Federal University of Bahia, Vitoria da Conquista, Brazil) ,  Cruz A. A. (WHO GARD Planning Group, Salvador, Brazil) ,  Silva J. da (Allergy Service, University Hospital of Federal University of Santa Catarina (HU-UFSC), Florianopolis, Brazil) ,  Serpa F. S. (Asthma Reference Center, Escola Superior de Ciencias da Santa Casa de Misericordia de Vitoria, Vitoria, Brazil) ,  Illario M. (Division for Health Innovation, Campania Region and Federico II University Hospital Naples (R&D and DISMET), Naples, Italy) ,  Menditto E. (CIRFF, Federico II University, Naples, Italy) ,  Cecchi L. (SOS Allergology and Clinical Immunology, USL Toscana Centro, Prato, Italy) ,  Monti R. (Department of Medical Sciences, Allergy and Clinical Immunology Unit, University of Torino & Mauriziano Hospital, Torino, Italy) ,  Napoli L. (Consortium of Pharmacies and Services COSAFER, Salerno, Italy) ,  Ventura M. T. (Unit of Geriatric Immunoallergology, University of Bari Medical School, Bari, Italy) ,  Feo G. De (Department of Medicine, Surgery and Dentistry “Scuola Medica Salernitana”, University of Salerno, Salerno, Italy) ,  Larenas-Linnemann D. (Center of Excellence in Asthma and Allergy, Hospital Medica Sur, Mexico City, Mexico) ,  Perez M. Fuentes (Mexico City, Mexico) ,  Villabolos Y. R. Huerta (Mexico City, Mexico) ,  Rivero-Yeverino D. (Puebla, Mexico) ,  Rodriguez-Zagal E. (Ciutad Mexico, Mexico) ,  Amat F. (Allergology Department, Centre de l’Asthme et des Allergies Hopital d’Enfants Armand-Trousseau (APHP), Paris, France) ,  Amat F. (UPMC Univ Paris 06, UMR_S 1136, Institut Pierre Louis d’Epidemiologie et de Sante Publique, Sorbonne Universites, Paris, France) ,  Annesi-Maesano I. (Epidemiology of Allergic and Respiratory Diseases, Department Institute Pierre Louis of Epidemiology and Public Health, INSERM, UPMC Sorbonne Universite, Medical School Saint Antoine, Paris, France) ,  Bosse I. (La Rochelle, France) ,  Demoly P. (Department of Respiratory Diseases, Montpellier University Hospital, Montpellier, France) ,  Devillier P. (UPRES EA220, Pole des Maladies des Voies Respiratoires, Hopital Foch, Universite Paris-Saclay, Suresnes, France) ,  Fontaine J. F. (Reims, France) ,  Just J. (Allergology Department, Centre de l’Asthme et des Allergies Hopital d’Enfants Armand-Trousseau (APHP), Paris, France) ,  Just J. (UPMC Univ Paris 06, UMR_S 1136, Institut Pierre Louis d’Epidemiologie et de Sante Publique, Sorbonne Universites, Paris, France) ,  Kuna T. P. (Division of Internal Medicine, Asthma and Allergy, Barlicki University Hospital, Medical University of Lodz, Lodz, Poland) ,  Samolinski B. (Department of Prevention of Environmental Hazards and Allergology, Medical University of Warsaw, Warsaw, Poland) ,  Valiulis A. (Clinic of Children’s Diseases, and Institute of Health Sciences Department of Public Health, Vilnius University Institute of Clinical Medicine, Vilnius, Lithuania) ,  Valiulis A. (European Academy of Paediatrics (EAP/UEMS-SP), Brussels, Belgium) ,  Emuzyte R. (Clinic of Children’s Diseases, Faculty of Medicine, Vilnius University, Vilnius, Lithuania) ,  Kvedariene V. (Faculty of Medicine, Vilnius University, Vilnius, Lithuania) ,  Ryan D. (Woodbrook Medical Centre, Loughborough, UK) ,  Ryan D. (Allergy and Respiratory Research Group, Usher Institute of Population Health Sciences and Informatics, University of Edinburgh, Medical School, Edinburgh, UK) ,  Sheikh A. (Centre of Medical Informatics, Usher Institute of Population Health Sciences and Informatics, The University of Edinburgh, Edinburgh, UK) ,  Schmidt-Grendelmeier P. (Allergy Unit, Department of Dermatology, University Hospital of Zurich, Zuerich, Switzerland) ,  Klimek L. (Center for Rhinology and Allergology, Wiesbaden, Germany) ,  Klimek L. (Department of Otorhinolaryngology, Head and Neck Surgery, Universitaetsmedizin Mannheim, Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany) ,  Pfaar O. (Center for Rhinology and Allergology, Wiesbaden, Germany) ,  Pfaar O. (Department of Otorhinolaryngology, Head and Neck Surgery, Universitaetsmedizin Mannheim, Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany) ,  Bergmann K. C. (Comprehensive Allergy-Centre-Charite, Department of Dermatology and Allergy, Charite - Universitaetsmedizin Berlin, Berlin, Germany) ,  Bergmann K. C. (Global Allergy and Asthma European Network (GA2LEN), Berlin, Germany) ,  Mosges R. (Institute of Medical Statistics, and Computational Biology, Medical Faculty, University of Cologne, Cologne, Germany) ,  Mosges R. (CRI-Clinical Research International-Ltd, Hamburg, Germany) ,  Zuberbier T. (Comprehensive Allergy-Centre-Charite, Department of Dermatology and Allergy, Charite - Universitaetsmedizin Berlin, Berlin, Germany) ,  Zuberbier T. (Global Allergy and Asthma European Network (GA2LEN), Berlin, Germany) ,  Roller-Wirnsberger R. E. (Department of Internal Medicine, Medical University of Graz, Graz, Austria) ,  Tomazic P. (Department of ENT, Medical University of Graz, Graz, Austria) ,  Fokkens W. J. (Department of Otorhinolaryngology, Academic Medical Centre, Amsterdam, The Netherlands) ,  Chavannes N. H. (Department of Public Health and Primary Care, Leiden University Medical Center, Leiden, The Netherlands) ,  Reitsma S. (Department of Otorhinolaryngology, Academic Medical Centre, Amsterdam, The Netherlands) ,  Anto J. M. (ISGlobAL, Centre for Research in Environmental Epidemiology (CREAL), Barcelona, Spain) ,  Anto J. M. (IMIM (Hospital del Mar Research Institute), Barcelona, Spain) ,  Anto J. M. (CIBER Epidemiologia y Salud Publica (CIBERESP), Barcelona, Spain) ,  Anto J. M. ,  Cardona V. ,  Dedeu T. ,  Dedeu T. ,  Mullol J. ,  Mullol J. ,  Haahtela T. ,  Salimaeki J. ,  Toppila-Salmi S. ,  Valovirta E. ,  Valovirta E. ,  Gemicioglu B. ,  Yorgancioglu A. ,  Yorgancioglu A. ,  Papadopoulos N. ,  Papadopoulos N. ,  Prokopakis E. P. ,  Bosnic-Anticevich S. ,  O’Hehir R. ,  O’Hehir R. ,  Ivancevich J. C. ,  Neffen H. ,  Zernotti E. ,  Kull I. ,  Melen E. ,  Melen E. ,  Wickman M. ,  Bachert C. ,  Hellings P. (Euforea, Brussels, Belgium) ,  Hellings P. ,  Hellings P. ,  Palkonen S. ,  Bindslev-Jensen C. ,  Eller E. ,  Waserman S. ,  Sova M. ,  Vries G. De ,  Eerd M. van ,  Agache I. ,  Casale T.
資料名： Clinical and Translational Allergy (Web)  (Clinical and Translational Allergy (Web))
巻： 8  号： 1  ページ： 45  発行年： 2018年 
JST資料番号： U7468A  ISSN： 2045-7022  資料種別： 逐次刊行物 (A)
記事区分： 文献レビュー  発行国： イギリス (GBR)  言語： 英語 (EN)

抄録/ポイント： 消費者スマート機器上で走行する評価のようなmHealthはますます人気があり,医療と健康の結果に大いに影響する可能性を持っている。しかし,それは破壊的であり,達成された結果は常に目標に到達しない。アレルギー性鼻炎(ARIA)はアレルギー性鼻炎(AR)におけるモバイル技術を用いた現実生活に適したケア経路に対する最も良い証拠に基づくアプローチを用いてガイドラインから進化している。患者は,薬理学で調剤されている過剰な薬剤を使用する。患者を中心とした共有意思決定と自己管理に基づく共有意思決定は,規範であるべきである。フェーズ3 ARIAイニシアティブであるモバイル航空機ネットワークK(MASK)は,自由に利用可能なMASK app(AllEnergy Diary,Android,iOSプラットフォーム)に基づいている。マスクは16言語で利用可能であり,23か国で展開されている。本論文では,MASKで使用される方法と今日まで得られた重要な結果を概観した。これらは,患者の新しい表現型特性化,アレルギー性鼻炎の作業生産性への影響の確認,および実際の生活における治療パターンを含む。ほとんどの患者は自己医薬品と思われ,しばしば非接着性で,ガイドラインに従わない。さらに,Allergy DiaryはAR薬物を区別することができる。MASKの潜在的有用性は,Allergy Diaryを用いた新しいHorizon2020プロジェクトであるPOLLAR(AsthmaとRhinitisに関する大気汚染の影響)によってさらに探究されるであろう。Copyright 2019 The Author(s) All rights reserved. Translated from English into Japanese by JST.【JST・京大機械翻訳】

シソーラス用語： 治療法 ,  消費者 ,  意思決定 ,  *喘息 ,  大気汚染 ,  携帯電話 ,  *ディジタル方式 ,  航空機 ,  キャラクタリゼーション ,  位相 ,  *鼻炎 ,  ネットワーク ,  言語
準シソーラス用語： 規範 ,  健康 , 【Automatic Indexing@JST】

著者キーワード (7件)： APP ,  ARIA ,  喘息 ,  ケア経路 ,  マスク ,  健康管理 ,  鼻炎

分類 (1件)： 免疫性疾患・アレルギー性疾患一般  (GD04010C)

引用文献 (71件)：

• Allergy; Allergic rhinitis and its impact on asthma (ARIA) 2008 update (in collaboration with the World Health Organization, GA(2)LEN and AllerGen); J Bousquet, N Khaltaev, AA Cruz, J Denburg, WJ Fokkens, A Togias; 63; Suppl 86; 2008; 8-160; 10.1111/j.1398-9995.2007.01620.x; citation_id=CR1
• J Allergy Clin Immunol Pract; Impact of rhinitis on work productivity: a systematic review; O Vandenplas, D Vinnikov, PD Blanc, I Agache, C Bachert, M Bewick; 6; 4; 2018; 1274-1286; 10.1016/j.jaip.2017.09.002; citation_id=CR2
• J Allergy Clin Immunol; Unmet needs in severe chronic upper airway disease (SCUAD); J Bousquet, C Bachert, GW Canonica, TB Casale, AA Cruz, RJ Lockey; 124; 3; 2009; 428-433; 10.1016/j.jaci.2009.06.027; citation_id=CR3
• J Allergy Clin Immunol; Uniform definition of asthma severity, control, and exacerbations: document presented for the World Health Organization Consultation on Severe Asthma; J Bousquet, E Mantzouranis, AA Cruz, N Ait-Khaled, CE Baena-Cagnani, ER Bleecker; 126; 5; 2010; 926-938; 10.1016/j.jaci.2010.07.019; citation_id=CR4
• Clin Transl Allergy; Endotype-driven treatment in chronic upper airway diseases; G Greve, PW Hellings, WJ Fokkens, B Pugin, B Steelant, SF Seys; 7; 2017; 22; 10.1186/s13601-017-0157-8; citation_id=CR5

タイトルに関連する用語 (9件)： マスク ,  現実 ,  世界 ,  証拠 ,  鼻炎 ,  喘息 ,  ディジタル ,  統合 ,  個人